Gan & Lee Pharmaceuticals. (SHA:603087)
68.12
-0.19 (-0.28%)
Oct 28, 2026, 9:45 AM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 40.55 billion as of October 27, 2026. It is the 3,030th most valuable company in the world and the 357th biggest in China. Its market cap has decreased by 1.01% in one year.
Market Cap
40.55B
Enterprise Value
36.60B
Revenue
4.37B
Global Rank
Country Rank
#357 China
PE Ratio
34.06
ChartMarket Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 40.55B, an increase of 10.89%. That is a compound annual growth rate of 1.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 42.87B | 5.81% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 29.80B |
| Intco Medical Technology | 27.48B |
| iRay Group | 24.08B |
| Andon Health | 21.82B |
| Zhende Medical | 21.12B |
| Winner Medical | 17.21B |
| Micro-Tech (Nanjing) Co.,Ltd | 14.86B |
| Shenyang Xingqi Pharmaceutical | 11.80B |